The article examines the objective, findings, and clinical context described in Mass Spectrometry Imaging Maps Intact Proteins in Tissue.
Approach:
Sample preparation: Fresh-frozen tissue sections were washed with ethanol and chloroform to remove lipids; ethanol also precipitated proteins to help limit their movement.
Imaging: Nano-DESI used a liquid bridge formed by two capillaries to extract molecules as the tissue moved beneath the probe. A shear-force probe maintained the sampling distance; the tip was approximately 10 micrometers, with about 7-micrometer line spacing.
Protein identification: Extracted proteins produced multiply charged ions for top-down tandem mass spectrometry. Proteoforms were identified by matching intact masses and fragmentation patterns to database records.
Key Findings:
Representative mouse-brain images mapped proteoforms of myelin basic protein, acyl-CoA-binding protein, cytochrome c oxidase subunit 6B1, and cytoplasmic dynein light chain 2.
Targeted tandem mass spectrometry can be performed on an adjacent tissue section after imaging identifies regions of interest.
The method provides label-free spatial information about intact proteins and their modifications.
Interpretation:
The workflow maps selected intact proteoforms in tissue while preserving their spatial context, which is lost when samples are homogenized.
Limitations:
Current nano-DESI experiments typically detect tens of proteoforms rather than the full tissue proteome; reported targets are mostly abundant proteins smaller than 20 kilodaltons.
Higher spatial resolution reduces the material collected per location and weakens protein signals.
Thicker tissue sections may offset signal loss but can create a less uniform surface and increase the risk of capillary blockage.
The authors identified sensitivity, ionization efficiency, spectral processing, and fragmentation as areas for improvement.
Conclusion:
The authors’ previous work mapped approximately 40 proteoforms representing 19 proteins in rat brain tissue.
